Consumption of ultra-processed products and wheezing respiratory diseases in children: The SENDO project

Laura Moreno-Galarraga1, Iratxe Martín-Álvarez2, Alejandro Fernández-Montero3

  • 1Servicio de Pediatría, Complejo Hospital de Navarra, Servicio Navarro de Salud, Pamplona, Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain.

Anales De Pediatria
|May 30, 2021
PubMed

Insights

High consumption of ultra-processed foods (UP) in children is linked to a higher prevalence of wheezing respiratory diseases like asthma and bronchitis. This study highlights the importance of diet in pediatric respiratory health.

Area of Science:

  • Pediatric Nutrition
  • Respiratory Health
  • Public Health

Background:

  • Ultra-processed foods (UP) consumption is linked to various adult diseases.
  • The impact of UP on pediatric respiratory conditions remains less understood.

Purpose of the Study:

  • To investigate the association between ultra-processed food consumption and wheezing respiratory diseases in children.
  • Specifically examining asthma and bronchitis/recurrent wheezing prevalence.

Main Methods:

  • Cross-sectional study within the Spanish SENDO project involving 513 children.
  • Ultra-processed food intake quantified via semi-quantitative food frequency questionnaires.
  • Statistical analysis using Odds Ratios and mixed regression models to assess associations.

Main Results:

  • High UP consumption (39.9% of total calories) was associated with an 87% increase in wheezing disease prevalence (OR: 1.87).
  • Higher UP intake significantly multiplied the prevalence of bronchitis/recurrent wheezing by 2.12 (95% CI: 1.10-4.05).

Conclusions:

  • A direct relationship exists between ultra-processed food consumption and the prevalence of wheezing diseases in children.
  • Findings suggest dietary patterns significantly influence pediatric respiratory health.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
898
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K